Discover 889 paid clinical trials in Birmingham, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 889
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
for
Alopecia Areata
Location: Birmingham AL, Indianapolis IN, Bexley OH, Tulsa OK,
Sponsor: Pfizer
Sex: All
Age: 12+
Code: NCT06873945
Phase3, Recruiting
A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment
for
Hypothalamic Obesity, Prader-Willi Syndrome, PWS
Location: Birmingham AL, Nashville TN, Chicago IL, Boston MA,
Sponsor: Rhythm Pharmaceuticals, Inc.
Sex: All
Age: 12 - 65
Code: NCT06239116
Phase1, Phase2, Recruiting
New
Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas
for
MPNST, NF1, Sarcoma
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18 - 70+
Code: NCT05253131
Phase2, Recruiting
KRT-232 in Combination With TL-895 for the Treatment of R/R MF and KRT-232 for the Treatment of JAKi Intolerant MF
for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Birmingham AL, Lake City FL, Urbana IL, New York NY,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT04640532
Phase1, Phase2, Recruiting
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
for
Recurrent Childhood Acute Myeloid Leukemia,
Location: Birmingham AL, Atlanta GA, Memphis TN, St Louis MO,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 18
Code: NCT06247787
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Streamlined Treatment of Pulmonary Exacerbations in Pediatrics
for
Cystic Fibrosis
Location: Birmingham AL, Atlanta GA, Charleston SC, St Louis MO,
Sponsor: University of Washington, the Collaborative Health Studies Coordinating Center
Sex: All
Age: 3 - 18
Code: NCT06654752
Recruiting
Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age
for
Lymphatic Malformation
Location: Birmingham AL, Nashville TN, Little Rock AR,
Sponsor: Protara Therapeutics
Sex: All
Age: 0 - 18
Code: NCT05871970
Phase2, Recruiting
Cord Clamping Among Neonates With Congenital Heart Disease
for
Congenital Heart Disease (CHD)
Location: Birmingham AL, Nashville TN, Jackson MS, Columbia SC,
Sponsor: Carl Backes, MD
Sex: All
Age: 0
Code: NCT06153459
Recruiting
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
for
Neuroblastoma
Location: Birmingham AL, Augusta GA, Little Rock AR,
Sponsor: Giselle Sholler
Sex: All
Age: 1 - 21
Code: NCT05489887
Phase2, Recruiting
Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS
for
Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome (MODS),
Location: Birmingham AL, Atlanta GA, Little Rock AR,
Sponsor: Nationwide Children's Hospital
Sex: All
Age: 0 - 17
Code: NCT05267821
Phase2, Phase3, Recruiting
Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency
for
Pyridox(am)Ine 5'-Phosphate Oxidase Deficiency
Location: Birmingham AL, Akron OH, Boston MA, Aurora CO,
Sponsor: Medicure
Sex: All
Age: 0+
Code: NCT04706013
Phase3, Recruiting
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors